EAI045

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2016-2018
01220162018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Lung cancer is the leading cause of cancer deaths. Epidermal growth factor receptor (EGFR) kinase domain mutations are a common… (More)
Is this relevant?
2018
2018
BACKGROUND The third-generation EGFR tyrosine kinase inhibitor osimertinib has been approved in many countries to treat advanced… (More)
Is this relevant?
Review
2017
Review
2017
The third-generation tyrosine kinase inhibitors (TKI), AZD9291 (osimertinib) and CO-1686 (rociletinib) of epidermal growth factor… (More)
Is this relevant?
Highly Cited
2016
Highly Cited
2016
The epidermal growth factor receptor (EGFR)-directed tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib and afatinib are… (More)
Is this relevant?
Review
2016
Review
2016
T790M mutation is the most common mechanism for resistance to first- and second-generation tyrosine kinase inhibitors (TKI) for… (More)
  • figure 1
Is this relevant?